Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29970R204 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Merck & Co., Inc.
13G/A
|
20.0% |
2/3/2025
Event 1/31/2025
|
|
| Merck & Co., Inc. | 20.0% | ||
| Merck Sharp & Dohme LLC | 20.0% | ||
| Merck Global Health Innovation Fund, LLC | 20.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q1 | 1 | 1.21 M | $4.52 M |
| 2025 Q4 | 1 | 1.21 M | $5.79 M |
| 2025 Q3 | 2 | 1.21 M | $4.57 M |
| 2025 Q2 | 2 | 1.21 M | $2.97 M |
| 2025 Q1 | 2 | 1.21 M | $2.25 M |
| 2024 Q4 | 10 | 806 k | $682 k |
| 2024 Q3 | 10 | 549 k | $1.71 M |
| 2024 Q2 | 8 | 456 k | $1.32 M |
| 2024 Q1 | 9 | 382 k | $1.22 M |
| 2023 Q4 | 1 | 10.0 k | $6.86 k |